EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Chrysin Alleviates Diabetic Angiopathies via Targeting KDR and Downregulating the KANK4/Talin-1/PI3K/AKT Pathway

Peng Xu iD, Lijuan Zheng, Xifeng Wei, Xinzhi Li, Dongmei Xi, Yanli Guo, Yanming Wang, Ketao Ma iD

Drug Design, Development and Therapy · 2026-11 · Volume 20 · 1-23

DOI: 10.2147/dddt.s615355 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2026-11. Verfasst von Peng Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Xinjiang Endemic and Ethnic Diseases, Ministry of Education, School of Medicine, Shihezi University, Shihezi, 832003, People's Repu…. Hauptthemen laut MEDLINE: Flavonoids, Diabetic Angiopathies. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FlavonoidsDiabetic AngiopathiesAnimalsMiceProto-Oncogene Proteins c-aktMice, Inbred C57BLDown-RegulationMalePhosphatidylinositol 3-KinasesMolecular Docking SimulationSignal TransductionCell ProliferationDiabetes Mellitus, ExperimentalDose-Response Relationship, DrugCells, CulturedStructure-Activity RelationshipMolecular Structure

Stichwörter der Autor:innen

KANK4Talin-1/PI3K/AKTbioinformatics analysischrysindiabetic angiopathy

Substanzen

FlavonoidschrysinProto-Oncogene Proteins c-aktPhosphatidylinositol 3-Kinases

Autor:innen und Institutionen

  • Key Laboratory of Xinjiang Endemic and Ethnic Diseases, Ministry of Education, School of Medicine, Shihezi University, Shihezi, 832003, People's Republic of China.
  • NHC Key Laboratory of Prevention and Treatment of Central Asia High Incidence Diseases, First Affiliated Hospital, School of Medicine, Shihezi University, Shihezi, 832003, People's Republic of China.
  • Department of Physiology, School of Medicine, Shihezi University, Shihezi, 832003, People's Republic of China.
  • Department of Blood Transfusion, First People's Hospital of Zhaoqing City, Zhaoqing, 526000, People's Republic of China.
  • Department of Pathophysiolog, School of Medicine, Shihezi University, Shihezi, 832003, People's Republic of China.

ORCID-Profile: Peng Xu, Ketao Ma

Zitieren

APA

Xu, P., Zheng, L., Wei, X., Li, X., Xi, D., Guo, Y., Wang, Y., & Ma, K. (2026). Chrysin Alleviates Diabetic Angiopathies via Targeting KDR and Downregulating the KANK4/Talin-1/PI3K/AKT Pathway. Drug Design, Development and Therapy, Volume 20, 1-23. https://doi.org/10.2147/dddt.s615355

Vancouver

Xu P, Zheng L, Wei X, Li X, Xi D, Guo Y, et al. Chrysin Alleviates Diabetic Angiopathies via Targeting KDR and Downregulating the KANK4/Talin-1/PI3K/AKT Pathway. Drug Design, Development and Therapy. 2026;Volume 20:1-23. doi:10.2147/dddt.s615355

BibTeX
@article{Xu2026,
  author = {Xu, Peng and Zheng, Lijuan and Wei, Xifeng and Li, Xinzhi and Xi, Dongmei and Guo, Yanli and Wang, Yanming and Ma, Ketao},
  title = {Chrysin Alleviates Diabetic Angiopathies via Targeting KDR and Downregulating the KANK4/Talin-1/PI3K/AKT Pathway},
  journal = {Drug Design, Development and Therapy},
  year = {2026},
  volume = {Volume 20},
  pages = {1--23},
  doi = {10.2147/dddt.s615355}
}
Kostenlos starten →